These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 316382)

  • 21. The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients--a pharmacokinetic model.
    Pahlka RB; Sonnad JR
    Health Phys; 2006 Sep; 91(3):227-37. PubMed ID: 16891898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
    Tuttle RM; Leboeuf R; Robbins RJ; Qualey R; Pentlow K; Larson SM; Chan CY
    J Nucl Med; 2006 Oct; 47(10):1587-91. PubMed ID: 17015892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of thyrotoxicosis with 125-iodine: results in 93 patients 3 to 5 years after treatment, and comparison with 131-iodine therapy (author's transl)].
    Glanzmann Ch; Horst W
    Strahlentherapie; 1979 Jan; 155(1):1-5. PubMed ID: 760268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the efficacy of iodine-131 for thyroid ablation.
    Comtois R; Thériault C; Del Vecchio P
    J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 131I therapy of toxic and non-toxic goiters.
    Beckers C
    Q J Nucl Med; 1999 Dec; 43(4):291-6. PubMed ID: 10731779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
    J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The radiation biology of the thyroid.
    Malone JF
    Curr Top Radiat Res Q; 1975 Oct; 10(4):263-368. PubMed ID: 53121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased uptake after fractionated ablative doses of iodine-131.
    Wu HS; Hseu HH; Lin WY; Wang SJ; Liu YC
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):167-73. PubMed ID: 15351912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radio-iodine therapy of toxic adenoma of the thyroid (author's transl)].
    Heinze HG; Pfeifer KJ; Lichtenstein Z
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2203-8. PubMed ID: 1175469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early changes of protein-bound iodine, butanol-extractable iodine, conversion factor and radioactive protein-bound iodine during treatment of thyrotoxicosis and thyroid cancer with 131-I.
    Bednár J; Nĕmec J; Soutorová M; Röhling S
    Nucl Med (Stuttg); 1969 Oct; 8(3):256-65. PubMed ID: 4191344
    [No Abstract]   [Full Text] [Related]  

  • 31. [Radionuclide therapy of thyroid disease--radioactive iodine therapy].
    Kusakabe K; Maki M
    Kaku Igaku; 1993 Jul; 30(7):813-9. PubMed ID: 8377305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [131 iodine: medical use. Carcinogenic and genetic effects].
    Schlumberger M; De Vathaire F
    Ann Endocrinol (Paris); 1996; 57(3):166-76. PubMed ID: 8949411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two mechanisms for hypothyroidism after 131I therapy.
    Malone JF; Cullen MJ
    Lancet; 1976 Jul; 2(7976):73-5. PubMed ID: 59154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 131I activity in urine to the sewer system due to thyroidal treatments.
    Andrés C; Barquero R; Tortosa R; Nuñez C; del Castillo A; Vega-Carrillo HR; Alonso D
    Health Phys; 2011 Aug; 101 Suppl 2():S110-5. PubMed ID: 21709491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical and radiobiological bases of the use of 125I in the management of thyrotoxicosis.
    Reddy AR
    Radiat Environ Biophys; 1976 Oct; 13(3):205-14. PubMed ID: 790444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evaluation of urine activity and external dose rate from patients receiving radioiodine therapy for thyroid cancer.
    Demir M; Parlak Y; Cavdar I; Yeyin N; Tanyildizi H; Gümüser G; Sayit E; Erees S; Sayman H
    Radiat Prot Dosimetry; 2013; 156(1):25-9. PubMed ID: 23535081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation dose assessments in radioiodine (131I) therapy. 1. The necessity for in vivo quantitation and dosimetry in the treatment of carcinoma of the thyroid.
    Schlesinger T; Flower MA; McCready VR
    Radiother Oncol; 1989 Jan; 14(1):35-41. PubMed ID: 2928556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium as an adjunct to radioiodine therapy for thyrotoxicosis.
    Turner JG; Brownlie BE; Rogers TG
    Lancet; 1976 Mar; 1(7960):614-5. PubMed ID: 55895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation effects of iodine-125 and iodine-131 on the overactive rat thyroid.
    Bremner WF; Kennedy JS
    Strahlentherapie; 1978 Jun; 154(6):413-8. PubMed ID: 96552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observations on radioiodide therapy of hyperthyroidism.
    Spencer RP
    Int J Nucl Med Biol; 1978; 5(4-5):195-7. PubMed ID: 744699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.